Also trades as: 0H8T.L (LSE) · $vol 0M
ACRS NASDAQ
Aclaris Therapeutics, Inc.
1W: -14.8%
1M: -29.0%
3M: -20.0%
YTD: +52.4%
1Y: +134.8%
3Y: -34.1%
5Y: -75.7%
$4.39
-0.02 (-0.45%)
Weekly Expected Move ±11.7%
$3
$4
$4
$5
$5
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$8M
Revenue
-51.0% YoY
$-76M
Net Income
+43.8% YoY
$-62M
Free Cash Flow
-35.6% YoY
85.8%
Gross Margin
-1487.9%
Op. Margin
-1320.1%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-59.1%
ROA-41.1%
ROIC-206.5%
Valuation
P/E-7.6
P/B5.0
EV/EBITDA-8.8
Leverage
Debt/Equity0.00
Current Ratio3.46
Interest Cov.0.0x
Quality Scores
Piotroski F3/9
Altman Z-0.52
Beneish M27.69